BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Furler J, O'Neal D, Speight J, Blackberry I, Manski-Nankervis JA, Thuraisingam S, de La Rue K, Ginnivan L, Doyle R, Holmes-Truscott E, Khunti K, Dalziel K, Chiang J, Audehm R, Kennedy M, Clark M, Jenkins A, Lake AJ, Januszewski AS, Catchpool M, Liew D, Clarke P, Best J. Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial. Lancet Diabetes Endocrinol 2020;8:17-26. [PMID: 31862147 DOI: 10.1016/S2213-8587(19)30385-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Simonson GD, Bergenstal RM, Johnson ML, Davidson JL, Martens TW. Effect of Professional CGM (pCGM) on Glucose Management in Type 2 Diabetes Patients in Primary Care. J Diabetes Sci Technol 2021;15:539-45. [PMID: 33719598 DOI: 10.1177/1932296821998724] [Reference Citation Analysis]
2 Cheng AYY, Feig DS, Ho J, Siemens R; Diabetes Canada Clinical Practice Guidelines Expert Working Group., Diabetes Canada Clinical Practice Guidelines Steering Committee. Blood Glucose Monitoring in Adults and Children with Diabetes: Update 2021. Can J Diabetes 2021;45:580-7. [PMID: 34511234 DOI: 10.1016/j.jcjd.2021.07.003] [Reference Citation Analysis]
3 Yan R, Cai T, Jiang L, Jing T, Cai L, Xie X, Su X, Xu L, He K, Cheng L, Cheng C, Liu B, Hu Y, Ma J. Real-Time Flash Glucose Monitoring Had Better Effects on Daily Glycemic Control Compared With Retrospective Flash Glucose Monitoring in Patients With Type 2 Diabetes on Premix Insulin Therapy. Front Endocrinol 2022;13:832102. [DOI: 10.3389/fendo.2022.832102] [Reference Citation Analysis]
4 Kerr D, Edelman S, Vespasiani G, Khunti K. New digital health technologies for insulin initiation and optimization for people with type 2 diabetes. Endocr Pract 2022:S1530-891X(22)00484-0. [PMID: 35452813 DOI: 10.1016/j.eprac.2022.04.006] [Reference Citation Analysis]
5 Hua X, Catchpool M, Clarke P, Blackberry I, Chiang J, Holmes-Truscott E, Jenkins A, Khunti K, O'Neal D, Speight J, Furler J, Manski-Nankervis JA, Dalziel K; GP-OSMOTIC Study Group. Cost-effectiveness of professional-mode flash glucose monitoring in general practice among adults with type 2 diabetes: Evidence from the GP-OSMOTIC trial. Diabet Med 2021;:e14747. [PMID: 34806780 DOI: 10.1111/dme.14747] [Reference Citation Analysis]
6 Daly A, Hovorka R. Technology in the management of type 2 diabetes: Present status and future prospects. Diabetes Obes Metab 2021;23:1722-32. [PMID: 33950566 DOI: 10.1111/dom.14418] [Reference Citation Analysis]
7 Golledge J, Fernando M, Lazzarini P, Najafi B, G Armstrong D. The Potential Role of Sensors, Wearables and Telehealth in the Remote Management of Diabetes-Related Foot Disease. Sensors (Basel). 2020;20. [PMID: 32823514 DOI: 10.3390/s20164527] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
8 Idris I, Annamalai N, Aung T, Binnian I, Gibb FW, Malik MIA, Ramtoola S. Hypoglycaemia in type 2 diabetes treated with pre-mixed insulin. Diabet Med 2021;:e14684. [PMID: 34464470 DOI: 10.1111/dme.14684] [Reference Citation Analysis]
9 Depczynski B, Poynten A. Acceptance and Effect of Continuous Glucose Monitoring on Discharge From Hospital in Patients With Type 2 Diabetes: Open-label, Prospective, Controlled Study. JMIR Diabetes 2022;7:e35163. [PMID: 35532995 DOI: 10.2196/35163] [Reference Citation Analysis]
10 Kieu A, King J, Govender RD, Östlundh L. The Benefits of Utilizing Continuous Glucose Monitoring of Diabetes Mellitus in Primary Care: A Systematic Review. J Diabetes Sci Technol. [DOI: 10.1177/19322968211070855] [Reference Citation Analysis]